These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 18620598)

  • 1. The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients.
    Jensen JU; Lundgren B; Hein L; Mohr T; Petersen PL; Andersen LH; Lauritsen AO; Hougaard S; Mantoni T; Bømler B; Thornberg KJ; Thormar K; Løken J; Steensen M; Carl P; Petersen JA; Tousi H; Søe-Jensen P; Bestle M; Hestad S; Andersen MH; Fjeldborg P; Larsen KM; Rossau C; Thomsen CB; Ostergaard C; Kjaer J; Grarup J; Lundgren JD
    BMC Infect Dis; 2008 Jul; 8():91. PubMed ID: 18620598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
    Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
    BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.
    Jensen JU; Hein L; Lundgren B; Bestle MH; Mohr TT; Andersen MH; Thornberg KJ; Løken J; Steensen M; Fox Z; Tousi H; Søe-Jensen P; Lauritsen AØ; Strange D; Petersen PL; Reiter N; Hestad S; Thormar K; Fjeldborg P; Larsen KM; Drenck NE; Ostergaard C; Kjær J; Grarup J; Lundgren JD;
    Crit Care Med; 2011 Sep; 39(9):2048-58. PubMed ID: 21572328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin increase in early identification of critically ill patients at high risk of mortality.
    Jensen JU; Heslet L; Jensen TH; Espersen K; Steffensen P; Tvede M
    Crit Care Med; 2006 Oct; 34(10):2596-602. PubMed ID: 16915118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal Procalcitonin Intervention Study (NeoPInS): Effect of Procalcitonin-guided decision making on duration of antibiotic therapy in suspected neonatal early-onset sepsis: A multi-centre randomized superiority and non-inferiority Intervention Study.
    Stocker M; Hop WC; van Rossum AM
    BMC Pediatr; 2010 Dec; 10():89. PubMed ID: 21143869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis.
    Uzzan B; Cohen R; Nicolas P; Cucherat M; Perret GY
    Crit Care Med; 2006 Jul; 34(7):1996-2003. PubMed ID: 16715031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis.
    Prkno A; Wacker C; Brunkhorst FM; Schlattmann P
    Crit Care; 2013 Dec; 17(6):R291. PubMed ID: 24330744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
    Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
    Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
    Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials.
    Kopterides P; Siempos II; Tsangaris I; Tsantes A; Armaganidis A
    Crit Care Med; 2010 Nov; 38(11):2229-41. PubMed ID: 20729729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Old and new biomarkers for predicting high and low risk microbial infection in critically ill patients with new onset fever: a case for procalcitonin.
    Hoeboer SH; Alberts E; van den Hul I; Tacx AN; Debets-Ossenkopp YJ; Groeneveld AB
    J Infect; 2012 May; 64(5):484-93. PubMed ID: 22248983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial.
    Bloos F; Trips E; Nierhaus A; Briegel J; Heyland DK; Jaschinski U; Moerer O; Weyland A; Marx G; Gründling M; Kluge S; Kaufmann I; Ott K; Quintel M; Jelschen F; Meybohm P; Rademacher S; Meier-Hellmann A; Utzolino S; Kaisers UX; Putensen C; Elke G; Ragaller M; Gerlach H; Ludewig K; Kiehntopf M; Bogatsch H; Engel C; Brunkhorst FM; Loeffler M; Reinhart K;
    JAMA Intern Med; 2016 Sep; 176(9):1266-76. PubMed ID: 27428731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*.
    Debiane L; Hachem RY; Al Wohoush I; Shomali W; Bahu RR; Jiang Y; Chaftari AM; Jabbour J; Al Shuaibi M; Hanania A; Pravinkumar SE; Schuetz P; Raad I
    Crit Care Med; 2014 Dec; 42(12):2500-7. PubMed ID: 25083975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin to guide taking blood cultures in the intensive care unit; a cluster-randomized controlled trial.
    van der Geest PJ; Mohseni M; Nieboer D; Duran S; Groeneveld ABJ
    Clin Microbiol Infect; 2017 Feb; 23(2):86-91. PubMed ID: 27746396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome.
    Simon L; Saint-Louis P; Amre DK; Lacroix J; Gauvin F
    Pediatr Crit Care Med; 2008 Jul; 9(4):407-13. PubMed ID: 18496408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin in the recognition of complications in critically ill surgical patients.
    Meyer ZC; Schreinemakers JM; Mulder PG; Schrauwen L; de Waal RA; Ermens AA; van der Laan L
    J Surg Res; 2014 Apr; 187(2):553-8. PubMed ID: 24315546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Antibiotic Discontinuation Strategies on Mortality and Infectious Complications in Critically Ill Septic Patients: A Meta-Analysis and Trial Sequential Analysis.
    Arulkumaran N; Khpal M; Tam K; Baheerathan A; Corredor C; Singer M
    Crit Care Med; 2020 May; 48(5):757-764. PubMed ID: 32191414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.